Clifford Swan Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $271K | Buy |
541
+62
| +13% | +$29.8K | 0.01% | 303 |
|
|
2026
Q1 | $235K | Hold |
479
| – | – | 0.01% | 308 |
|
|
2025
Q4 | $278K | Hold |
479
| – | – | 0.01% | 276 |
|
|
2025
Q3 | $232K | Sell |
479
-30
| -6% | -$14K | 0.01% | 306 |
|
|
2025
Q2 | $206K | Hold |
509
| – | – | 0.01% | 306 |
|
|
2025
Q1 | $253K | Buy |
509
+58
| +13% | +$31.4K | 0.01% | 284 |
|
|
2024
Q4 | $235K | Hold |
451
| – | – | 0.01% | 288 |
|
|
2024
Q3 | $279K | Buy |
451
+28
| +7% | +$16.6K | 0.01% | 277 |
|
|
2024
Q2 | $234K | Sell |
423
-177
| -30% | -$101K | 0.01% | 284 |
|
|
2024
Q1 | $349K | Sell |
600
-155
| -21% | -$87K | 0.01% | 251 |
|
|
2023
Q4 | $401K | Buy |
755
+21
| +3% | +$10.2K | 0.02% | 231 |
|
|
2023
Q3 | $371K | Sell |
734
-11
| -1% | -$5.86K | 0.02% | 240 |
|
|
2023
Q2 | $389K | Buy |
745
+23
| +3% | +$12.4K | 0.02% | 241 |
|
|
2023
Q1 | $416K | Sell |
722
-5
| -0.7% | -$2.82K | 0.02% | 226 |
|
|
2022
Q4 | $401K | Buy |
727
+5
| +0.7% | +$2.65K | 0.02% | 226 |
|
|
2022
Q3 | $366K | Sell |
722
-50
| -6% | -$28K | 0.02% | 238 |
|
|
2022
Q2 | $420K | Buy |
772
+60
| +8% | +$33K | 0.02% | 238 |
|
|
2022
Q1 | $421K | Hold |
712
| – | – | 0.02% | 245 |
|
|
2021
Q4 | $475K | Sell |
712
-32
| -4% | -$20K | 0.02% | 244 |
|
|
2021
Q3 | $473K | Buy |
744
+155
| +26% | +$85.1K | 0.02% | 242 |
|
|
2021
Q2 | $318K | Hold |
589
| – | – | 0.01% | 264 |
|
|
2021
Q1 | $269K | Hold |
589
| – | – | 0.01% | 288 |
|
|
2020
Q4 | $274K | Hold |
589
| – | – | 0.01% | 281 |
|
|
2020
Q3 | $260K | Buy |
+589
| New | +$243K | 0.01% | 277 |
|
|
2020
Q1 | – | Sell |
-1,719
| Closed | -$559K | – | 320 |
|
|
2019
Q4 | $559K | Hold |
1,719
| – | – | 0.03% | 206 |
|
|
2019
Q3 | $501K | Hold |
1,719
| – | – | 0.03% | 204 |
|
|
2019
Q2 | $505K | Buy |
1,719
+95
| +6% | +$26.2K | 0.03% | 206 |
|
|
2019
Q1 | $445K | Sell |
1,624
-96
| -6% | -$23.9K | 0.02% | 218 |
|
|
2018
Q4 | $385K | Hold |
1,720
| – | – | 0.02% | 222 |
|
|
2018
Q3 | $420K | Hold |
1,720
| – | – | 0.02% | 219 |
|
|
2018
Q2 | $356K | Hold |
1,720
| – | – | 0.02% | 240 |
|
|
2018
Q1 | $355K | Sell |
1,720
-371
| -18% | -$77.9K | 0.02% | 240 |
|
|
2017
Q4 | $397K | Sell |
2,091
-39
| -2% | -$7.47K | 0.02% | 230 |
|
|
2017
Q3 | $403K | Buy |
2,130
+39
| +2% | +$7.06K | 0.02% | 233 |
|
|
2017
Q2 | $365K | Buy |
+2,091
| New | +$351K | 0.02% | 242 |
|
Other funds holding TMO
Clifford Swan Investment Counsel's TMO Position: Q2 2026 in Review
Clifford Swan Investment Counsel increased its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, buying an estimated $29.8K and bringing the position to 541 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #303.
Clifford Swan Investment Counsel first reported a position in TMO in Q2 2017 and has held it in 35 quarters since. The position peaked at $559K in Q4 2019. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Clifford Swan Investment Counsel held 541 shares of Thermo Fisher Scientific worth $271K as of Q2 2026.
- Clifford Swan Investment Counsel bought 62 Thermo Fisher Scientific shares in Q2 2026, an estimated $29.8K.
- Thermo Fisher Scientific made up 0.01% of Clifford Swan Investment Counsel's portfolio in Q2 2026, its #303 holding.
- Clifford Swan Investment Counsel first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 35 quarters since.
- Clifford Swan Investment Counsel's Thermo Fisher Scientific position peaked at $559K in Q4 2019.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Clifford Swan Investment Counsel's 13F filing for Q2 2026, filed 20 Aug 2026.